These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30064013)

  • 1. Whole-Body Lung Function Test-Derived Outcome Predictors in Allogenic Stem Cell Transplantation.
    Scheidl S; Zinke-Cerwenka W; Flick H; Gaal S; Avian A; Greinix H; Olschewski H
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):129-136. PubMed ID: 30064013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of bronchiolitis obliterans syndrome stage 0p in chronic graft-versus-host disease of the lung.
    Abedin S; Yanik GA; Braun T; Pawarode A; Magenau J; Goldstein SC; Levine JE; Kitko CL; Couriel DR
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1127-31. PubMed ID: 25687798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late-Onset Noninfectious Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation: Single-Center Experience.
    Işık Ö; Erol S; Cengiz Seval G; Gürün Kaya A; Toprak SK; Özdemir Kumbasar Ö
    Exp Clin Transplant; 2024 May; 22(5):373-380. PubMed ID: 38970280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Azithromycin on Airflow Decline-Free Survival After Allogeneic Hematopoietic Stem Cell Transplant: The ALLOZITHRO Randomized Clinical Trial.
    Bergeron A; Chevret S; Granata A; Chevallier P; Vincent L; Huynh A; Tabrizi R; Labussiere-Wallet H; Bernard M; Chantepie S; Bay JO; Thiebaut-Bertrand A; Thepot S; Contentin N; Fornecker LM; Maillard N; Risso K; Berceanu A; Blaise D; Peffault de La Tour R; Chien JW; Coiteux V; Socié G;
    JAMA; 2017 Aug; 318(6):557-566. PubMed ID: 28787506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic GVHD and pretransplantation abnormalities in pulmonary function are the main determinants predicting worsening pulmonary function in long-term survivors after stem cell transplantation.
    Savani BN; Montero A; Srinivasan R; Singh A; Shenoy A; Mielke S; Rezvani K; Karimpour S; Childs R; Barrett AJ
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1261-9. PubMed ID: 17162207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term pulmonary function testing in pediatric bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
    Walther S; Rettinger E; Maurer HM; Pommerening H; Jarisch A; Sörensen J; Schubert R; Berres M; Bader P; Zielen S; Jerkic SP
    Pediatr Pulmonol; 2020 Jul; 55(7):1725-1735. PubMed ID: 32369682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the Conditioning Regimen Dose Intensity Before Autologous Stem Cell Transplantation on the Pulmonary Function Test Abnormalities in Patients With Lymphoma and Multiple Myeloma: Single Center Experience.
    Bou Akl I; Matar M; Khalil PB; Massoud R; Ghaoui N; Karout L; Zahreddine A; Bazarbachi A; El-Cheikh J
    Clin Lymphoma Myeloma Leuk; 2020 Jun; 20(6):371-376.e1. PubMed ID: 32151585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
    Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
    Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance of Early Declines in Pulmonary Function After Allogeneic Hematopoietic Stem Cell Transplantation.
    Yadav H; Torghabeh MH; Hogan WJ; Limper AH
    Respir Care; 2023 Oct; 68(10):1406-1416. PubMed ID: 37253610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of lung function after myeloablative and 2 Gy of total body irradiation-based regimens for hematopoietic stem cell transplantation.
    Chien JW; Maris MB; Sandmaier BM; Maloney DG; Storb RF; Clark JG
    Biol Blood Marrow Transplant; 2005 Apr; 11(4):288-96. PubMed ID: 15812394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary function changes in long-term survivors of chronic myelogenous leukemia after allogeneic bone marrow transplantation: a Taiwan experience.
    Chiou TJ; Tung SL; Wang WS; Tzeng WF; Yen CC; Fan FS; Liu JH; Chen PM
    Cancer Invest; 2002; 20(7-8):880-8. PubMed ID: 12449718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Lung Function on Bronchiolitis Obliterans Syndrome and Outcome after Allogeneic Hematopoietic Cell Transplantation with Reduced-Intensity Conditioning.
    Duque-Afonso J; Ihorst G; Waterhouse M; Zeiser R; Wäsch R; Bertz H; Müller-Quernheim J; Finke J; Marks R; Prasse A
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2277-2284. PubMed ID: 29964193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factor and Clinical Outcome of Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation.
    Rhee CK; Ha JH; Yoon JH; Cho BS; Min WS; Yoon HK; Lee JW
    Yonsei Med J; 2016 Mar; 57(2):365-72. PubMed ID: 26847288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening with spirometry is a useful predictor of later development of noninfectious pulmonary syndromes in patients undergoing allogeneic stem cell transplantation.
    Thompson PA; Lim A; Panek-Hudson Y; Tacey M; Hijazi R; Ng AP; Szer J; Ritchie D; Bajel A
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):781-6. PubMed ID: 24548876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of pulmonary complications after nonmyeloablative and conventional allogeneic hematopoietic cell transplant.
    Diab KJ; Yu Z; Wood KL; Shmalo JA; Sheski FD; Farber MO; Wilkes DS; Nelson RP
    Biol Blood Marrow Transplant; 2012 Dec; 18(12):1827-34. PubMed ID: 22766224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant.
    Cheng GS; Storer B; Chien JW; Jagasia M; Hubbard JJ; Burns L; Ho VT; Pidala J; Palmer J; Johnston L; Mayer S; Crothers K; Pusic I; Lee SJ; Williams KM
    Ann Am Thorac Soc; 2016 Nov; 13(11):1932-1939. PubMed ID: 27513368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.
    Williams KM; Cheng GS; Pusic I; Jagasia M; Burns L; Ho VT; Pidala J; Palmer J; Johnston L; Mayer S; Chien JW; Jacobsohn DA; Pavletic SZ; Martin PJ; Storer BE; Inamoto Y; Chai X; Flowers MED; Lee SJ
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):710-716. PubMed ID: 26475726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of lung transplantation after allogeneic hematopoietic stem cell transplantation.
    Cheng GS; Edelman JD; Madtes DK; Martin PJ; Flowers ME
    Biol Blood Marrow Transplant; 2014 Aug; 20(8):1169-75. PubMed ID: 24727334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretransplant pulmonary function tests predict risk of mortality following fractionated total body irradiation and allogeneic peripheral blood stem cell transplant.
    Singh AK; Karimpour SE; Savani BN; Guion P; Hope AJ; Mansueti JR; Ning H; Altemus RM; Wu CO; Barrett AJ
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):520-7. PubMed ID: 16965994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.